Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 07, 2015 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing's Syndrome

DUBLIN, Ireland and TREVOSE, Pa., Dec. 7, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP) today announced that the United States Patent and Trademark Office (USPTO) issued a patent...
December 01, 2015 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at the 26th Annual Oppenheimer Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the 26th Annual Oppenheimer Healthcare...
November 23, 2015 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Arctic Biotech Seminar

DUBLIN, Ireland and TREVOSE, Pa., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the Arctic Biotech Seminar in Oslo,...
November 18, 2015 08:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Update on Corporate Progress

Strongbridge Advances Clinical Development of Rare Endocrine Disease Portfolio With COR-003, COR-004 and COR-005 Strongbridge Expands Key Functional Area Expertise With Senior Hires Strongbridge...
November 04, 2015 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at the Stifel 2015 Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that management will be presenting at the Stifel 2015 Healthcare Conference...
November 03, 2015 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference

DUBLIN, Ireland and TREVOSE, Pa., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) today announced that results from a secondary efficacy analysis of the completed Phase 2...
October 21, 2015 16:05 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Closing of Initial U.S. Public Offering

DUBLIN, Ireland and TREVOSE, Pa., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) announced today the closing of its initial U.S. public offering of 2,500,000 ordinary...
October 16, 2015 09:20 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Pricing of Its Initial U.S. Public Offering

DUBLIN, Ireland and TREVOSE, Pa., Oct. 16, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP) announced today the pricing of its initial U.S. public offering of 2,500,000 ordinary...